XML 39 R6.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Operating Activities:    
Net loss $ (197,536,000) $ (140,305,000)
Adjustments to reconcile net loss to net cash used in operating activities:    
Impairment of goodwill and indefinite-lived intangible assets 89,485,000 0
Impairment of long-lived assets 65,232,000 0
Depreciation and amortization 13,238,000 8,765,000
Accretion of discounts and impairment on marketable securities (2,031,000) (324,000)
Amortization in operating lease right-of-use assets 5,945,000 6,357,000
Deferred income tax benefit (6,195,000) 0
Stock-based compensation 21,256,000 23,402,000
Other non-cash adjustments 1,119,000 0
Net changes in operating assets and liabilities:    
Interest receivable 192,000 (175,000)
Accounts receivable 2,530,000 1,491,000
Prepaid expenses and other assets 5,159,000 (5,848,000)
Accounts payable and other accrued liabilities (5,220,000) 9,443,000
Accrued compensation and employee benefits (4,182,000) (1,225,000)
Deferred revenues (159,671,000) (64,956,000)
Lease liabilities (3,737,000) (3,298,000)
Other non-current liabilities 112,000 95,000
Net cash used in operating activities (174,304,000) (166,578,000)
Investing Activities:    
Purchases of marketable securities (59,551,000) (225,621,000)
Maturities of marketable securities 193,858,000 254,990,000
Purchases of property and equipment (18,484,000) (12,697,000)
Net cash provided by investing activities 115,823,000 16,672,000
Financing Activities:    
Taxes paid related to net share settlement of equity awards (1,404,000) (1,962,000)
Proceeds from exercise of stock options 0 124,000
Net cash provided by financing activities 14,421,000 65,125,000
Effect of exchange rate changes on cash, cash equivalents, and restricted cash 130,000 479,000
Net decrease in cash, cash equivalents, and restricted cash (43,930,000) (84,302,000)
Cash, cash equivalents, and restricted cash, beginning of period 101,944,000 180,372,000
Cash, cash equivalents, and restricted cash, end of period 58,014,000 96,070,000
Supplemental cash flow disclosures:    
Property and equipment included in unpaid liabilities 2,757,000 3,927,000
Tenant improvement allowance included in contra-lease liability 0 1,531,000
At the Market Offering    
Financing Activities:    
Proceeds from at-the-market offering/ issuance of common stock 15,106,000 65,848,000
Employee Stock    
Financing Activities:    
Proceeds from at-the-market offering/ issuance of common stock $ 719,000 $ 1,115,000